Fed. Circ. Finds Boston Scientific Patent Invalid
An appeals court has reversed a decision against a Johnson & Johnson Inc. subsidiary accused of infringing a Boston Scientific Corp. patent after ruling that the stent described in the patent...To view the full article, register now.
Already a subscriber? Click here to view full article